Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

APOL

Apollon Formularies (APOL)

Apollon Formularies plc
Date:
Sort by:
 Showing the most relevant articles for your search:AQSE:APOL
DateTimeSourceHeadlineSymbolCompany
05/03/20246:59AMUK RegulatoryApollon Formularies Plc - Notice of GMAQSE:APOLApollon Formularies plc
05/01/20249:00AMUK RegulatoryApollon Formularies Plc - Intention to Withdraw from AQUISAQSE:APOLApollon Formularies plc
02/20/20244:59AMUK RegulatoryApollon Formularies Plc - CANCER CELL KILLING RESULTS PUBLISHED IN THE PEER-REVIEWED ONLINE JOURNAL OF COMPLEMENTARY AND ALTERNATIVE MEDICINE (OJCAM)AQSE:APOLApollon Formularies plc
01/02/20242:18AMUK RegulatoryApollon Formularies Plc Result of AGMAQSE:APOLApollon Formularies plc
12/05/20235:59AMUK RegulatoryApollon Formularies Plc Notice of AGMAQSE:APOLApollon Formularies plc
11/21/20235:51AMUK RegulatoryApollon Formularies Plc Sproutly and Apollon Conclude Due Diligence, Paving Way for Asset Purchase AgreementAQSE:APOLApollon Formularies plc
09/29/20231:00AMUK RegulatoryApollon Formularies Plc Interim Results for the 6 Months ended 30 June 2023AQSE:APOLApollon Formularies plc
09/19/20233:18AMUK RegulatoryApollon Formularies Plc Execution of Binding LOI with Sproutly Canada, Inc.AQSE:APOLApollon Formularies plc
08/03/20234:51AMUK RegulatoryApollon Formularies Plc Resignation of Non-Executive DirectorAQSE:APOLApollon Formularies plc
08/02/20236:19AMUK RegulatoryApollon Formularies Plc Update on Global Hemp GroupAQSE:APOLApollon Formularies plc
07/24/20235:00AMUK RegulatoryApollon Formularies Plc Apollon grants an Exclusive Licence Agreement to PureCann, South AfricaAQSE:APOLApollon Formularies plc
06/30/202311:32AMUK RegulatoryApollon Formularies plc Final Results for the Year Ended 31 December 2022AQSE:APOLApollon Formularies plc
05/10/202311:05AMUK RegulatoryApollon Formularies Plc Update on Global Hemp GroupAQSE:APOLApollon Formularies plc
04/11/20238:00AMUK RegulatoryApollon Formularies Plc Result of General MeetingAQSE:APOLApollon Formularies plc
03/21/20237:00AMUK RegulatoryApollon Formularies Plc 28 day due diligence extension for Asset saleAQSE:APOLApollon Formularies plc
03/15/20232:00AMUK RegulatoryApollon Formularies plc Notice of General MeetingAQSE:APOLApollon Formularies plc
01/12/20231:00AMUK RegulatoryApollon Formularies plc Execution of Binding Letter of Intent with GHGAQSE:APOLApollon Formularies plc
12/30/20226:37AMUK RegulatoryApollon Formularies plc Result of AGMAQSE:APOLApollon Formularies plc
12/02/20221:00AMUK RegulatoryApollon Formularies plc Notice of AGMAQSE:APOLApollon Formularies plc
09/30/20223:50AMUK RegulatoryApollon Formularies plc Interim ResultsAQSE:APOLApollon Formularies plc
09/13/20221:02AMUK RegulatoryApollon Formularies plc Directors' DealingAQSE:APOLApollon Formularies plc
08/02/20223:11AMUK RegulatoryApollon Formularies plc Total Voting RightsAQSE:APOLApollon Formularies plc
07/26/20221:00AMUK RegulatoryApollon Formularies plc Acquisition of Citiva & Director Loan AgreementAQSE:APOLApollon Formularies plc
06/30/202210:29AMUK RegulatoryApollon Formularies plc Final ResultsAQSE:APOLApollon Formularies plc
06/30/20226:33AMUK RegulatoryApollon Formularies Plc Total Voting RightsAQSE:APOLApollon Formularies plc
06/17/20227:23AMUK RegulatoryApollon Formularies plc Issue of EquityAQSE:APOLApollon Formularies plc
05/05/20226:07AMUK RegulatoryApollon Formularies plc Apollon Acquires Intellectual Property from AionAQSE:APOLApollon Formularies plc
03/02/20221:01AMUK RegulatoryApollon Formularies plc Joint Venture with Tri-Medi Canna, South AfricaAQSE:APOLApollon Formularies plc
02/09/20221:00AMUK RegulatoryApollon Formularies plc Intention to Join OTC & Migrate to Larger ExchangeAQSE:APOLApollon Formularies plc
02/03/202212:59AMUK RegulatoryApollon Formularies plc Grand Opening of International Cancer InstituteAQSE:APOLApollon Formularies plc
 Showing the most relevant articles for your search:AQSE:APOL

Your Recent History

Delayed Upgrade Clock